CIK 1757283
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 68.78% | 5 |
| Health Care Equipment & Supplies | 30.36% | 1 |
| Unclassified | 0.86% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | Health Care | 30.36% |
| 2 | EVMN | Evommune, Inc. | Health Care | 24.66% |
| 3 | MLYS | Mineralys Therapeutics, Inc. | Health Care | 24.38% |
| 4 | AGMB | Agomab Therapeutics NV | Health Care | 9.12% |
| 5 | IVA | Inventiva S.A. | Health Care | 5.70% |
| 6 | ABVX | Abivax S.A. | Health Care | 4.92% |
| 7 | NYXH | NYXOAH S A | Unclassified | 0.86% |
6/7 names classified · sector 99.1% of weight · industry 99.1% · mkt cap 79.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/7 names) · unclassified 100.0%: KMTS, EVMN, MLYS, AGMB, IVA, ABVX, NYXH. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | KMTSKESTRA MED TECHNOLOGIES LTD | 2,695,192 | $54M | 30.4% | ADD 6% |
| 2 | EVMNEVOMMUNE INC | 1,897,362 | $44M | 24.7% | HOLD |
| 3 | MLYSMINERALYS THERAPEUTICS INC | 1,591,917 | $43M | 24.4% | HOLD |
| 4 | AGMBAGOMAB THERAPEUTICS NV | 1,538,702 | $16M | 9.1% | NEW |
| 5 | IVAINVENTIVA SA | 1,818,181 | $10M | 5.7% | HOLD |
| 6 | ABVXABIVAX SA | 78,125 | $9M | 4.9% | HOLD |
| 7 | NYXHNYXOAH S A | 522,057 | $2M | 0.9% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| KMTSKESTRA MED TECHNOLOGIES LTD | — | — | — | — | 2.5M | 2.7M | $54M |
| EVMNEVOMMUNE INC | — | — | — | — | 1.9M | 1.9M | $44M |
| MLYSMINERALYS THERAPEUTICS INC | — | — | — | — | 1.6M | 1.6M | $43M |
| AGMBAGOMAB THERAPEUTICS NV | — | — | — | — | — | 1.5M | $16M |
| IVAINVENTIVA SA | — | — | — | — | 1.8M | 1.8M | $10M |
| ABVXABIVAX SA | — | — | — | — | 78K | 78K | $9M |
| NYXHNYXOAH S A | — | — | — | — | — | 522K | $2M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
